Terms: = Lymphoma AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
41 results:
1. Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the treatment of Relapsed or Refractory Follicular lymphoma After Two or More Lines of Systemic Therapy in the USA.
Lin SW; Shapouri S; Parisé H; Bercaw E; Wu M; Kim E; Matasar M
Pharmacoeconomics; 2024 May; 42(5):569-582. PubMed ID: 38300452
[TBL] [Abstract] [Full Text] [Related]
2. treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
Zeng D; Fang Y; Fei Y; Liang R; Ye H; Liang Y; Sun X; Wang M; Huang H; Qiu L; Che Y; Liu P; Wang Y; Pan T; Lv Y; Deng J; Yi S; He Y; Xiao L; Lv H; Feng J; Zhang H; Zhou H; Zou D; Cai Q
Int J Cancer; 2023 Sep; 153(5):1016-1025. PubMed ID: 37204683
[TBL] [Abstract] [Full Text] [Related]
3. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Fukuta T; Tanaka T; Hashimoto T; Isahaya K; Kubo Y; Yamano Y; Satomi K; Hiraoka N; Shirakawa N; Arakawa A; Ogawa C; Nishimura N; Aoki J; Ito A; Inamoto Y; Kim SW; Fukuda T
Int J Hematol; 2023 Jun; 117(6):933-940. PubMed ID: 36705847
[TBL] [Abstract] [Full Text] [Related]
4. Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
Wen Q; Ge J; Lei Y; Zhang Y; Kong X; Wang W; Hou H; Wang Z; Qian S; Ding M; Dong M; Zhu L; Zhang M; Zhang X; Chen Q
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3989-4003. PubMed ID: 36030432
[TBL] [Abstract] [Full Text] [Related]
5. Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
Akin S; Hosing C; Khouri I; Ahmed S; Alousi A; Fowler N; Joseph J; Truxillo J; Ramdial JL; Maadani F; Rondon G; Daher M; Im JS; Steiner R; Westin J; Iyer SP; Dabaja B; Anderlini P; Popat UR; Qazilbash MH; Flowers CR; Shpall E; Champlin RE; Nieto Y; Srour SA
Blood Adv; 2022 Apr; 6(7):2267-2274. PubMed ID: 35008100
[TBL] [Abstract] [Full Text] [Related]
6. Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis.
Bröckelmann PJ; Müller H; Gillessen S; Yang X; Koeppel L; Pilz V; Marinello P; Kaskel P; Raut M; Fuchs M; Borchmann P; Engert A; von Tresckow B
Leukemia; 2022 Mar; 36(3):772-780. PubMed ID: 34628472
[TBL] [Abstract] [Full Text] [Related]
7. A cost-effectiveness analysis of front-line treatment strategies in early-stage follicular lymphoma.
Tobin JWD; Crothers A; Ma TE; Mollee P; Gandhi MK; Scuffham P; Hapgood G
Leuk Lymphoma; 2021 Dec; 62(14):3484-3492. PubMed ID: 34323129
[TBL] [Abstract] [Full Text] [Related]
8. Cost Effectiveness Analysis of Tisagenlecleucel for the treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell lymphoma in Japan.
Wakase S; Teshima T; Zhang J; Ma Q; Fujita T; Yang H; Chai X; Qi CZ; Liu Q; Wu EQ; Igarashi A
Transplant Cell Ther; 2021 Jun; 27(6):506.e1-506.e10. PubMed ID: 33823168
[TBL] [Abstract] [Full Text] [Related]
9. Selinexor in Combination with R-CHOP for Frontline treatment of Non-Hodgkin lymphoma: Results of a Phase I Study.
Seymour EK; Khan HY; Li Y; Chaker M; Muqbil I; Aboukameel A; Ramchandren R; Houde C; Sterbis G; Yang J; Bhutani D; Pregja S; Reichel K; Huddlestun A; Neveux C; Corona K; Landesman Y; Shah J; Kauffman M; Shacham S; Mohammad RM; Azmi AS; Zonder JA
Clin Cancer Res; 2021 Jun; 27(12):3307-3316. PubMed ID: 33785483
[TBL] [Abstract] [Full Text] [Related]
10. The effect of hospital care volume on overall survival of children with cancer in Southern Brazil.
Arancibia AM; De Farias CB; Brunetto AL; Roesler R; Gregianin LJ
Pediatr Blood Cancer; 2021 Mar; 68(3):e28779. PubMed ID: 33118699
[TBL] [Abstract] [Full Text] [Related]
11. treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
Liao W; Liu Y
Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
[TBL] [Abstract] [Full Text] [Related]
12. Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a U.S. Hospital's Perspective.
Yang H; Hao Y; Qi CZ; Chai X; Wu EQ
J Manag Care Spec Pharm; 2020 Aug; 26(8):971-980. PubMed ID: 32525730
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma].
Qiu YJ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):40-46. PubMed ID: 32023753
[No Abstract] [Full Text] [Related]
14. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.
Ayoub Z; Andraos T; Milgrom SA; Pinnix CC; Dabaja BS; Ng SP; Gunther JR; Khoury JD; Fowler NH; Neelapu SS; Samaniego F; Fayad LE; Nastoupil LJ
Leuk Lymphoma; 2019 Oct; 60(10):2432-2440. PubMed ID: 30942648
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular lymphoma.
Liang JH; Zhang YP; Xia J; Ding CY; Wu W; Wang L; Cao L; Zhu HY; Fan L; Li TN; Li JY; Xu W
Cancer Res Treat; 2019 Oct; 51(4):1479-1487. PubMed ID: 30913868
[TBL] [Abstract] [Full Text] [Related]
16. Minimal Residual Disease-guided Risk Restratification and Therapy Improves the Survival of Childhood Acute Lymphoblastic Leukemia: Experience From a Tertiary Children's Hospital in China.
Liao C; Xu X; Shen D; Song H; Xu W; Zhao F; Yang S; Shi S; Liang J; Li S; Tang Y
J Pediatr Hematol Oncol; 2019 Aug; 41(6):e346-e354. PubMed ID: 30640823
[TBL] [Abstract] [Full Text] [Related]
17. Survival after a cancer diagnosis among solid organ transplant recipients in the United States.
D'Arcy ME; Coghill AE; Lynch CF; Koch LA; Li J; Pawlish KS; Morris CR; Rao C; Engels EA
Cancer; 2019 Mar; 125(6):933-942. PubMed ID: 30624768
[TBL] [Abstract] [Full Text] [Related]
18. [Global and disease-free survival in a peruvian cohort of patients with acute lymphoblastic leukemia].
Castro-Arechaga S; Ronceros-Salas L; Vega-Centeno S; Moreno M; Soto A
Rev Peru Med Exp Salud Publica; 2018; 35(3):416-425. PubMed ID: 30517501
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. treatment phase affecting factors: A step towards better focussed counselling.
Alam A; Kumar A
Cancer Epidemiol; 2018 Dec; 57():53-59. PubMed ID: 30316108
[TBL] [Abstract] [Full Text] [Related]
20. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
[Next]
